DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 130 filers reported holding DERMIRA INC in Q3 2016. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,340,000 | +145.0% | 88,400 | +3.3% | 0.00% | 0.0% |
Q3 2019 | $547,000 | -31.0% | 85,600 | +3.3% | 0.00% | 0.0% |
Q2 2019 | $793,000 | -30.9% | 82,900 | -2.1% | 0.00% | 0.0% |
Q1 2019 | $1,148,000 | +187.0% | 84,700 | +52.1% | 0.00% | 0.0% |
Q4 2018 | $400,000 | -30.2% | 55,700 | +5.9% | 0.00% | 0.0% |
Q3 2018 | $573,000 | +18.4% | 52,600 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $484,000 | +15.2% | 52,600 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $420,000 | -71.3% | 52,600 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $1,463,000 | +8.8% | 52,600 | +5.6% | 0.00% | 0.0% |
Q3 2017 | $1,345,000 | -7.3% | 49,800 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $1,451,000 | -14.6% | 49,800 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,699,000 | +48.3% | 49,800 | +31.7% | 0.00% | 0.0% |
Q4 2016 | $1,146,000 | -2.9% | 37,800 | +8.3% | 0.00% | 0.0% |
Q3 2016 | $1,180,000 | +15.9% | 34,900 | +0.3% | 0.00% | 0.0% |
Q2 2016 | $1,018,000 | +116.1% | 34,800 | +47.5% | 0.00% | +100.0% |
Q1 2016 | $471,000 | -11.6% | 23,600 | +53.2% | 0.00% | 0.0% |
Q4 2015 | $533,000 | – | 15,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,984,364 | $55,185,000 | 7.74% |
NEA Management Company, LLC | 3,506,649 | $97,520,000 | 4.04% |
Avoro Capital Advisors LLC | 1,520,000 | $42,271,000 | 2.74% |
Iguana Healthcare Management, LLC | 100,000 | $2,781,000 | 1.81% |
Abingworth LLP | 70,000 | $1,947,000 | 1.41% |
DAFNA Capital Management LLC | 86,000 | $2,392,000 | 1.29% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $3,004,000 | 1.06% |
Opaleye Management Inc. | 100,000 | $2,781,000 | 0.89% |
New Leaf Venture Partners, L.L.C. | 61,109 | $1,699,000 | 0.80% |
Ghost Tree Capital, LLC | 100,000 | $2,781,000 | 0.65% |